top of page

PatientsCure     THERAPEUTICS

Patient Cure Therapeutics  is a pharmaceutical  company and we focus on  developing treatment drugs from preclinical trials to commercialization. 

We are currently developing Phase I  AAV    to deliver safe and effective gene replacement to the liver .This treatment  produces sustained therapeutic protein expression for diseases like haemophilia B and fabry disease.

These clinical trials will better lives for people with inherited systemic debilitating disease .


Our focus is on developing treatments for diseases with high unmet needs followed by expansion to address diseases in neurology and inflammation.

bottom of page